First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma

Cancer Discovery ◽

10.1158/2159-8290.cd-19-0555 ◽

2019 ◽

Vol 9 (12) ◽

pp. 1696-1707 ◽

Author(s):

Richard D. Kim ◽

Debashis Sarker ◽

Tim Meyer ◽

Thomas Yau ◽

Teresa Macarulla ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase I ◽

Phase I Study ◽

Download Full-text

Cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced or metastatic hepatocellular carcinoma (HCC): Data from an expansion cohort (EC) in a phase I study

Annals of Oncology ◽

10.1093/annonc/mdy487.004 ◽

2018 ◽

Vol 29 ◽

pp. x26 ◽

Author(s):

A.R. He ◽

G.J. Weiss ◽

G. Falchook ◽

N.S. Yee ◽

M. Gil-Martin ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase I ◽

Phase I Study ◽

Metastatic Hepatocellular Carcinoma ◽

Expansion Cohort

Download Full-text

Phase I Study of Stereotactic Body Radiotherapy followed by Ipilimumab with Nivolumab vs. Nivolumab alone in Unresectable Hepatocellular Carcinoma

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.900 ◽

2020 ◽

Vol 108 (3) ◽

pp. S149-S150

Author(s):

A. Juloori ◽

C.Y. Liao ◽

J.M. Lemons ◽

A.K. Singh ◽

R. Iyer ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase I ◽

Stereotactic Body Radiotherapy ◽

Phase I Study ◽

Unresectable Hepatocellular Carcinoma

Download Full-text

Phase I Study of the Bifunctional Fusion Protein Bintrafusp Alfa in Asian Patients with Advanced Solid Tumors, Including a Hepatocellular Carcinoma Safety‐Assessment Cohort

The Oncologist ◽

10.1634/theoncologist.2020-0249 ◽

2020 ◽

Vol 25 (9) ◽

Author(s):

Toshihiko Doi ◽

Yutaka Fujiwara ◽

Takafumi Koyama ◽

Masafumi Ikeda ◽

Christoph Helwig ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Fusion Protein ◽

Phase I ◽

Solid Tumors ◽

Phase I Study ◽

Safety Assessment ◽

Advanced Solid Tumors ◽

Asian Patients ◽

Bifunctional Fusion Protein

Download Full-text

Electrochemotherapy: new treatment approach for Hepatocellular Carcinoma: Results of phase I study

HPB ◽

10.1016/j.hpb.2019.10.1069 ◽

2019 ◽

Vol 21 ◽

pp. S905-S906

Author(s):

M. Dokić ◽

D. Stanisavljević ◽

M. Petrič ◽

A. Tomažič ◽

B. Trotovšek ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase I ◽

Phase I Study ◽

Treatment Approach ◽

Download Full-text

Phase I study of sorafenib in Japanese patients with hepatocellular carcinoma

Cancer Science ◽

10.1111/j.1349-7006.2007.00648.x ◽

2007 ◽

Vol 0 (0) ◽

pp. 071113200242005-??? ◽

Author(s):

Junji Furuse ◽

Hiroshi Ishii ◽

Kohei Nakachi ◽

Eiichiro Suzuki ◽

Satoshi Shimizu ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase I ◽

Phase I Study ◽

Japanese Patients

Download Full-text

Phase I study of miriplatin combined with transarterial chemotherapy using CDDP powder in patients with hepatocellular carcinoma

BMC Gastroenterology ◽

10.1186/1471-230x-12-127 ◽

2012 ◽

Vol 12 (1) ◽

Author(s):

Kenya Kamimura ◽

Takeshi Suda ◽

Yasushi Tamura ◽

Masaaki Takamura ◽

Takeshi Yokoo ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase I ◽

Download Full-text

Pharmacokinetics of intra-arterial applied liposomal encapsulated doxorubicin in liver metastases or hepatocellular carcinoma: A phase I study

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.13523 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 13523-13523

Author(s):

R. A. Hilger ◽

H. Richly ◽

M. Grubert ◽

M. Libicher ◽

D. Strumberg ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase I ◽

Liver Metastases ◽

Download Full-text

1206 Phase I study of Pazopanib (PAZ) in Hepatocellular Carcinoma (HCC): evaluation of clinical activity, Pharmacokinetics (PK), and Dynamic Contrast Enhanced MRI (DCE-MRI)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)70418-5 ◽

2009 ◽

Vol 7 (2) ◽

pp. 122 ◽

Author(s):

C.C. Yau ◽

P. Chen ◽

C. Curtis ◽

P. Murphy ◽

G. Parker ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase I ◽

Phase I Study ◽

Clinical Activity ◽

Dce Mri ◽

Dynamic Contrast Enhanced Mri ◽

Dynamic Contrast Enhanced ◽

Enhanced Mri ◽

Contrast Enhanced ◽

Contrast Enhanced Mri

Download Full-text

Phase I study of HLA-half matched allogeneic natural killer cell therapy in patients with hepatocellular carcinoma

Journal of Hepatology ◽

10.1016/s0168-8278(17)31713-0 ◽

2017 ◽

Vol 66 (1) ◽

pp. S632

Author(s):

Y.-B. Xie ◽

J.-Y. Zhang ◽

M. Shi ◽

F.-S. Wang

Keyword(s):

Hepatocellular Carcinoma ◽

Natural Killer Cell ◽

Cell Therapy ◽

Phase I ◽

Natural Killer ◽

Phase I Study ◽

Killer Cell ◽

Allogeneic Natural Killer Cell

Download Full-text

Complete hepatic venous isolation and extracorporeal chemofiltration as treatment for human hepatocellular carcinoma: A phase I study

Annals of Surgical Oncology ◽

10.1007/bf02303811 ◽

1994 ◽

Vol 1 (5) ◽

pp. 389-399 ◽

Author(s):

Steven A. Curley ◽

Robert A. Newman ◽

Thomas B. Dougherty ◽

George M. Fuhrman ◽

Diana L. Stone ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase I ◽

Phase I Study ◽

Human Hepatocellular Carcinoma

Download Full-text